Status:
COMPLETED
Clinical Study of Intermittent Positive Pressure Breathing (IPPB)
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Lung Diseases
Lung Diseases, Obstructive
Eligibility:
All Genders
30-74 years
Phase:
PHASE3
Brief Summary
To evaluate the efficacy of long-term intermittent positive pressure breathing (IPPB) treatment when used as an adjunct to the overall care of ambulatory outpatients with chronic obstructive pulmonary...
Detailed Description
BACKGROUND: Intermittent positive pressure breathing may be a useful adjunct therapy for patients with chronic obstructive pulmonary disease. It is, however, quite expensive; moreover, in 1976 its tr...
Eligibility Criteria
Men and women, ages 30 to 74, who were ambulatory and had symptomatic chronic bronchitis or emphysema.
Key Trial Info
Start Date :
November 1 1976
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000565
Start Date
November 1 1976
Last Update
April 14 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.